News

FluMist allows the vaccine to enter the nose, where the influenza virus usually enters the body, inducing protective immunity. AstraZeneca said that in clinical studies FluMist was effective

Intercell’s vaccine, which helps to prevent Japanese Encephalitis, has already been approved and launched in the USA, Europe, Canada and Australia. Ixiaro is a modern purified, inactivated vaccine

Peregrine Pharma said that the current study is based on the positive Phase II NSCLC study results, which showed an ORR of 43% (21 of 49 patients) and

Mr Kesaris is expected to report Chris Haudenschild, chairman and CEO of CliniComp and will oversee CliniComp’s financial, operating, marketing and sales functions. Most recently, Kesaris has worked

Asuragen manufactures the monitoring test, which is exclusively distributed by Life Technologies and runs on the Applied Biosystems CE-marked 7500 Fast Dx Real-Time PCR Instrument. The test monitors

Cubicin is approved in the US and many other markets as therapy for Staphylococcus aureus bloodstream infections (bacteremia), including right-sided endocarditis caused by methicillin-resistant S aureus (MRSA), and

As per the terms of the agreement, that was signed in July 2007, Silence and AstraZeneca are jointly collaborating in the identification and optimisation of five new siRNA

In the study, ISTA Pharma is expected to evaluate the safety and efficacy of three concentrations of Bepotastine Besilate, dosed twice daily, in an Environmental Exposure Chamber (EEC)

NEB said that the new products provide all the necessary enzymes and buffers for fast fragment library preparation. The Master Mix Set further streamlines the workflow, reducing the